This invention relates to the use of acylated alanine derivatives for the modulation, notably the inhibition of the activity of WIP1. Suitably, the present invention relates to the use of acylated alanine derivatives in the treatment of cancer.
-
Page/Page column 79
(2012/11/13)
More Articles about upstream products of 1404457-08-4